


Immunovant
Biotechnology Research • Manhattan, New York, United States • 201-500 Employees
Company overview
| Headquarters | 320 W 37th St, New York, 10018, US |
| Phone number | +19175803099 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Autoimmune Disease |
| Founded | 2018 |
| Employees | 201-500 |
| Socials |
Immunovant Email Formats
Immunovant uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@immunovant.com), used 90.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@immunovant.com | 90.9% |
{first initial}.{last name} | j.doe@immunovant.com | 8.3% |
About Immunovant
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. For U.S. residents only.
Immunovant revenue & valuation
| Annual revenue | $7,500,000 |
| Revenue per employee | $21,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $24,000,000 |
| Total funding | $900,000,000 |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Immunovant has 191 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Immunovant's funding history, including investment rounds, total capital raised, and key backers.
Immunovant Tech Stack
Discover the technologies and tools that power Immunovant's digital infrastructure, from frameworks to analytics platforms.
Cookie compliance
CDN
Web servers
JavaScript libraries
Security
Analytics
UI frameworks
Security
PaaS
Tag managers
JavaScript libraries
JavaScript libraries
Frequently asked questions
Key Contacts at Immunovant
4.8
40,000 users



